IHT Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.6M Buy
35,451
+5,230
+17% +$5.3M 0.76% 22
2025
Q4
$32.5M Sell
30,221
-1,465
-5% -$1.4M 0.79% 23
2025
Q3
$24.2M Buy
31,686
+750
+2% +$558K 0.61% 26
2025
Q2
$24.1M Buy
30,936
+659
+2% +$512K 0.66% 25
2025
Q1
$25M Buy
30,277
+12,213
+68% +$10.2M 0.78% 21
2024
Q4
$13.9M Sell
18,064
-1,113
-6% -$922K 0.45% 45
2024
Q3
$17M Sell
19,177
-27,255
-59% -$24.5M 0.48% 37
2024
Q2
$42M Sell
46,432
-11,843
-20% -$9.47M 1.57% 8
2024
Q1
$45.3M Sell
58,275
-406
-0.7% -$289K 1.82% 7
2023
Q4
$34.2M Sell
58,681
-656
-1% -$383K 1.53% 7
2023
Q3
$31.9M Sell
59,337
-1,416
-2% -$730K 1.62% 7
2023
Q2
$28.5M Buy
60,753
+40,854
+205% +$17.1M 1.48% 8
2023
Q1
$6.83M Buy
19,899
+2,364
+13% +$797K 0.39% 50
2022
Q4
$6.42M Buy
17,535
+589
+3% +$209K 0.4% 52
2022
Q3
$5.48M Buy
16,946
+3,778
+29% +$1.2M 0.42% 46
2022
Q2
$4.27M Buy
13,168
+535
+4% +$161K 0.38% 47
2022
Q1
$3.62M Buy
12,633
+455
+4% +$117K 0.27% 76
2021
Q4
$3.36M Buy
12,178
+129
+1% +$32.7K 0.25% 88
2021
Q3
$2.78M Sell
12,049
-3,082
-20% -$761K 0.23% 100
2021
Q2
$3.47M Buy
15,131
+568
+4% +$114K 0.22% 96
2021
Q1
$2.72M Buy
14,563
+2,108
+17% +$412K 0.2% 114
2020
Q4
$2.1M Buy
12,455
+152
+1% +$22.7K 0.17% 130
2020
Q3
$1.82M Buy
12,303
+807
+7% +$125K 0.18% 124
2020
Q2
$1.89M Sell
11,496
-586
-5% -$90K 0.26% 93
2020
Q1
$1.68M Buy
12,082
+283
+2% +$38.9K 0.24% 99
2019
Q4
$1.55M Sell
11,799
-133
-1% -$15.4K 0.18% 136
2019
Q3
$1.33M Buy
11,932
+1,077
+10% +$120K 0.18% 136
2019
Q2
$1.2M Buy
10,855
+588
+6% +$69.2K 0.17% 133
2019
Q1
$1.33M Sell
10,267
-404
-4% -$49.1K 0.22% 112
2018
Q4
$1.24M Buy
10,671
+671
+7% +$75K 0.24% 108
2018
Q3
$1.07M Buy
10,000
+332
+3% +$33.2K 0.23% 114
2018
Q2
$825K Buy
9,668
+439
+5% +$36.1K 0.21% 130
2018
Q1
$699K Sell
9,229
-144
-2% -$11.6K 0.19% 145
2017
Q4
$807K Sell
9,373
-48
-0.5% -$4.08K 0.21% 123
2017
Q3
$820K Buy
9,421
+6,988
+287% +$573K 0.35% 73
2017
Q2
$13 Sell
2,433
-339
-12% -$27.7K 0.01% 890
2017
Q1
$237K Sell
2,772
-131
-5% -$10.5K 0.16% 158
2016
Q4
$217K Buy
+2,903
New +$216K 0.16% 146

Other funds holding LLY

IHT Wealth Management's LLY Position: Q1 2026 in Review

IHT Wealth Management increased its Eli Lilly (LLY) stake by 17% in Q1 2026, buying an estimated $5.3M and bringing the position to 35,451 shares worth $32.6M. The position accounts for 0.76% of the portfolio, ranked #22.

IHT Wealth Management first reported a position in LLY in Q4 2016 and has held it in 38 quarters since. The position peaked at $45.3M in Q1 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • IHT Wealth Management held 35,451 shares of Eli Lilly worth $32.6M as of Q1 2026.
  • IHT Wealth Management bought 5,230 Eli Lilly shares in Q1 2026, an estimated $5.3M.
  • Eli Lilly made up 0.76% of IHT Wealth Management's portfolio in Q1 2026, its #22 holding.
  • IHT Wealth Management first reported a position in Eli Lilly in Q4 2016 and has held it in 38 quarters since.
  • IHT Wealth Management's Eli Lilly position peaked at $45.3M in Q1 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on IHT Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.